| Phrase | Consultant | Town | Special Interests |
| dementia and end of life care | *Consultant(s)* | *Towns* | Geriatric medicine, internal medicine, frailty, dementia and end of life care, medical education |
| Dialysis at the end of life | *Consultant(s)* | *Towns* | Dialysis at the end of life |
| end of life | *Consultant(s)* | *Towns* | General internal medicine, community geriatrics, end of life |
| End of life care | *Consultant(s)* | *Towns* | End of life care |
| end of life care | *Consultant(s)* | *Towns* | Complex health and social needs, acute frailty, end of life care |
| end of life care | *Consultant(s)* | *Towns* | Orthogeriatrics, complex care, end of life care |
| End of life care | *Consultant(s)* | *Towns* | End of life care, lymphoedema |
| End of life care | *Consultant(s)* | *Towns* | End of life care |
| end of life care | *Consultant(s)* | *Towns* | General internal medicine, end of life care |
| end of life care | *Consultant(s)* | *Towns* | Symptom management, cancer of unknown primary, end of life care |
| end of life care | *Consultant(s)* | *Towns* | Symptom control, pain medicine, end of life care |
| End of life care | *Consultant(s)* | *Towns* | End of life care |
| end of life care for renal patients | *Consultant(s)* | *Towns* | Vasculitis, acute nephritis, systemic lupus erythematosus - SLE, CKD - chronic kidney disease, end of life care for renal patients, scleroderma kidney disease |
| end stage liver failure | *Consultant(s)* | *Towns* | Hepatology, end stage liver failure, nutrition, enteral tube feeding, transplant |
| nutrition in end stage renal failure | *Consultant(s)* | *Towns* | Renal cancer, renal transplantation, peritoneal dialysis, metabolic renal stone disease, nutrition in end stage renal failure |
| recognition of end of life care and care implications | *Consultant(s)* | *Towns* | Complex cancer pain management, death rattle management, medical management of inoperable malignant bowel obstruction, recognition of end of life care and care implications, respiratory distress management in palliative end of life care |
| respiratory distress management in palliative end of life care | *Consultant(s)* | *Towns* | Complex cancer pain management, death rattle management, medical management of inoperable malignant bowel obstruction, recognition of end of life care and care implications, respiratory distress management in palliative end of life care |
| Sub PI in Chelsea II Study (Hydration at the end of life) | *Consultant(s)* | *Towns* | PI in MePFAC study: Methylphenidate v Placebo in management of fatigue in advanced cancer (RCT, double-blinded, trial completed), Sub PI in Chelsea II Study (Hydration at the end of life) |
| Symptom control in end stage disease | *Consultant(s)* | *Towns* | Symptom control in end stage disease, end-of-life care |
